Pharmacokinetics and Pharmacodynamics of Low Dose Mycophenolate Mofetil in HIV-Infected Patients Treated with Abacavir, Efavirenz and Nelfinavir

被引：0
|
作者：
Olga Millán
Mercé Brunet
Jaume Martorell
Felipe García
Elena Vidal
Isabel Rojo
Montserrat Plana
Teresa Gallart
Tomas Pumarola
Jose M. Miró
Jose M. Gatell
机构：
[1] Universitat de Barcelona,Servei Immunologia, Hospital Clínic, IDIBAPS
[2] Universitat de Barcelona,Servei Toxicologia, Hospital Clínic, IDIBAPS
[3] Universitat de Barcelona,Servei Infeccions, Hospital Clínic, IDIBAPS
[4] Universitate de Barcelona,Servei Microbiologia, Hospital Clínic, IDIBAPS
[5] Hospital Clinic de Barcelona,Servei Immunologia
来源：
Clinical Pharmacokinetics | 2005年 / 44卷
关键词：
Viral Load; Efavirenz; Mycophenolate Mofetil; Abacavir; Mycophenolic Acid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：525 / 538
页数：13
相关论文
共 50 条
  • [1] Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients
    Somchai Sriwiriyajan
    Werawath Mahatthanatrakul
    Wibool Ridtitid
    Sutep Jaruratanasirikul
    European Journal of Clinical Pharmacology, 2007, 63 : 479 - 483
  • [2] Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients
    Sriwiriyajan, Somchai
    Mahatthanatrakul, Werawath
    Ridtitid, Wibool
    Jaruratanasirikul, Sutep
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (05) : 479 - 483
  • [3] Weight related differences in the pharmacokinetics of abacavir in HIV-infected patients
    Jullien, V
    Tréluyer, JM
    Chappuy, H
    Dimet, J
    Rey, E
    Dupin, N
    Salmon, D
    Pons, G
    Urien, S
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (02) : 183 - 188
  • [4] Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil
    Brunet, M
    Cirera, I
    Martorell, J
    Vidal, E
    Millán, O
    Jiménez, O
    Rojo, I
    Londoño, MC
    Rimola, A
    TRANSPLANTATION, 2006, 81 (04) : 541 - 546
  • [5] Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patients
    Villani, P
    Regazzi, MB
    Castelli, F
    Viale, P
    Torti, C
    Seminari, E
    Maserati, R
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (05) : 712 - 715
  • [6] Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients
    Hsue, Priscilla Y.
    Hunt, Peter W.
    Wu, Yuaner
    Schnell, Amanda
    Ho, Jennifer E.
    Hatano, Hiroyu
    Xie, Yu
    Martin, Jeffrey N.
    Ganz, Peter
    Deeks, Steven G.
    AIDS, 2009, 23 (15) : 2021 - 2027
  • [7] Effect of Rifampicin on Efavirenz Pharmacokinetics in HIV-Infected Children With Tuberculosis
    Ren, Yuan
    Nuttall, James J. C.
    Eley, Brian S.
    Meyers, Tammy M.
    Smith, Peter J.
    Maartens, Gary
    McIlleron, Helen M.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (05) : 439 - 443
  • [8] In vivo platelet activation and platelet hyperreactivity in abacavir-treated HIV-infected patients
    Falcinelli, Emanuela
    Francisci, Daniela
    Belfiori, Barbara
    Petito, Eleonora
    Guglielmini, Giuseppe
    Malincarne, Lisa
    Mezzasoma, AnnaMaria
    Sebastiano, Manuela
    Conti, Valentina
    Giannini, Silvia
    Bonora, Stefano
    Baldelli, Franco
    Gresele, Paolo
    THROMBOSIS AND HAEMOSTASIS, 2013, 110 (02) : 349 - 357
  • [9] Reasons for early abacavir discontinuation in HIV-infected patients
    Peyriere, H
    Guillemin, V
    Lotthe, A
    Baillat, V
    Fabre, J
    Favier, C
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (10) : 1392 - 1397
  • [10] Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients
    Eric Dailly
    Olivier Tribut
    Pierre Tattevin
    Cédric Arvieux
    Philippe Perré
    François Raffi
    Pascale Jolliet
    European Journal of Clinical Pharmacology, 2006, 62 : 523 - 526
12345